Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading 6.1% Higher – Here’s Why

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s share price were up 6.1% on Wednesday . The company traded as high as $17.30 and last traded at $17.30. Approximately 3,033 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 21,523 shares. The stock had previously closed at $16.30.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. UBS Group initiated coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They set a “buy” rating and a $21.00 target price on the stock. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Down 1.6 %

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.